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Background
Patients with severe ischemic cardiomyopathy (ICM)
have reduced survival. The association between degree of
scarring, gender and survival is unclear in such patients.
We sought to determine, using delayed hyperenhance-
ment magnetic resonance imaging (DHE-MRI), if female
gender is associated with increased mortality in ICM
patients with severe left ventricular (LV) dysfunction.
Methods
349 patients (24% women) with severe ICM >/= 70% ste-
nosis in >/= 1 epicardial vessel on angiography and mean
LV ejection fraction (EF) 23%], that underwent DHE-MRI
(Siemens 1.5 T scanner, Erlangen, Germany) from 2003–
6 were studied. DHE-MR images were obtained in stand-
ard long and short axis orientations (covering the entire
LV), after injection of Gadolinium dimenglumine using
an inversion recovery spoiled gradient echo sequence: TE
4 msec, TR 8 msec, flip angle 300, bandwidth 140 Hz/
pixel, 23 k-space lines acquired every other RR-interval,
field of view (varied from 228–330 in the x-direction and
260–330 in the y-direction) and matrix size (varied from
140–180 in the x-direction and 256 in the y-direction).
For DHE-MRI analysis, a custom analysis package (VPT
software, Siemens, Erlangen, Germany) was used to man-
ually delineate endocardial and epicardial myocardial
edges. Scar was defined (as % of myocardium in a 17-seg-
ment model on custom software, Siemens Research) on
DHE-MR images, as intensity > 2 standard deviation
above viable myocardium. Transmurality score was
recorded in all segments as follows: 0 = no scar, 1 = 1–
25% scar, 2 = 26–50%, 3 = 51–75% and 4 = > 75%. Glo-
bal LV scar burden was calculated as transmurality score
for all segments/17. LV volumes, EF, demographic/clini-
cal data, history of cardiac transplantation and all-cause
mortality were recorded.
Results
There were 56 events (51 deaths and 5 cardiac transplan-
tations) over a mean follow up 2.6 ± 1.2 years. Character-
istics of men vs. women are shown in Table. On univariate
survival analysis, women had worse outcomes, compared
to men (log-rank p = 0.03 Figure 1), despite similar extent
of scar (Table 1).
Conclusion
In ICM patients with severely reduced LVEF, women have
worse outcomes, compared to men, despite similar risk
factors, LVEF, myocardial scar burden and smaller vol-
umes.
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Table 1: In ICM patients with severely reduced LVEF, women have worse outcomes, compared to men, despite similar risk factors, 
LVEF, myocardial scar burden and smaller volumes.
Total n = 349 Men (n = 265) Women (n = 84) p-value
Age (years) 66 ± 11 64 ± 12 0.20
Diabetes Mellitus (%) 75 (28) 24 (29) 0.9
Hypertension (%) 93 (35) 34 (40) 0.4
Betablockers (%) 150 (57) 51 (60) 0.6
Angiotensin converting enzyme inhibitors(%) 126 (48) 37 (44) 0.6
Statins (%) 142 (54) 47 (56) 0.70
History of coronary artery bypass grafting 22 (8) 7 (8) 0.9
LV ejection fraction (%) 23 ± 8 25 ± 8 0.23
LV enddiastolic volume (ml) 241 ± 107 189 ± 88 <0.001
LV endsystolic volume (ml) 142 ± 90 100 ± 68 0.001
Mean scar % on DHE-MRI 32 ± 21 29 ± 21 0.39
Number of segments with transmurality score ≥ 3 on 
DHE-MRI
8.2 ± 5 7.7 ± 5 0.36
Global LV scar burden on DHE-MRI 2.10 ± 1.1 2.00 ± 1.1 0.37
Post MRI revascularization (%) 72 (27) 17 (20) 0.20
Post-MRI ICD or CRT 70 (26) 25 (30) 0.55
Combined events (death or cardiac transplantation during 
follow-up) (%)*
31 (12%) death and 5 cardiac transplantations 20 (24) 0.03
DHE-MRI: delayed hyperenhancement magnetic resonance imaging, LV: left ventricle, ICD: implantable cardioverter defibrillator, CRT: cardiac 
resynchronization therapy
